Arkolith/Insider Trading/OCUL/Form 4

Lindstrom Richard L MD

DirectorOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed Feb 24, 2026
Net Buying
Open-Market Buys
$461K
Open-Market Sells
$0
Net Open-Market Flow
$461K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Buy(P)60K$7.66$461K247K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-019256) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML